Structured evidence table for Almond Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Almond Cholesterol Meta-Analysis | This persistent inflammatory response is a key biological mechanism linking obesity to increased risk of insulin resistance, type 2 diabetes, and cardiovascular complications [,,,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Cholesterol Meta-Analysis | Large epidemiological studies, including the Nurses’ Health Study and the ATTICA study, report that higher adherence to a MED-style dietary pattern is associated with lower concentrations of pro-inflammatory cytokines and immune cell counts [,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Cholesterol Meta-Analysis | 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Nuts are a core component of high-quality dietary patterns [] and may contribute substantially to the anti-inflammatory effects associated with these dietary patterns. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Cholesterol Meta-Analysis | 1 2 1 2 3 4 5 6 7 Obesity is a state of chronic low-grade systemic inflammation, characterized by elevated circulating concentrations of pro-inflammatory cytokines and measurable shifts in innate immune cell populations [,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Cholesterol Meta-Analysis | Conversely, a meta-analysis described in a report by the European Food Safety Authority (EFSA) on the tolerable upper intake level for dietary sugars identified a causal relationship with FS and risk of obesity and dyslipidemia from RCTs []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond Cholesterol Meta-Analysis | However, data from prospective cohorts did not suggest a positive relationship between intake of FS and risk of obesity or dyslipidemia []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond Cholesterol Meta-Analysis | Further, a 2025 meta-analysis of cohort studies found sugar-sweetened beverages (SSB), but not added sugars (nor total sugars), were related to increased risk of type 2 diabetes []. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
| Almond Cholesterol Meta-Analysis | 1 2 2 The value or threat of added and free sugars (FS) in the diet lacks scientific consensus. | 3 | Peregoy Jennifer A. (2026) | The Impact of Sugar Source on the Relationships Between Free Sugars Intake and Health: A Secondary Analysis |
Source documents